Clincosm LogoSign in Get a demo

myeloma

Showing 51 - 75 of 133
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

B Cell Lymphoma, B Cell Leukemia, Myeloma Trial in Wenzhou (CAR-CD19 T cell, CAR-BCMA T cell, CAR-GPC3 T cell)

Active, not recruiting
  • B Cell Lymphoma
  • +5 more
  • CAR-CD19 T cell
  • +5 more
  • Wenzhou, Zhejiang, China
    First Affiliated Hospital of Wenzhou Medical University
Oct 5, 2020

Myeloma Trial in Houston (Trisenox (Arsenic Trioxide), Velcade (Bortezomib), Melphalan)

Completed
Has Results
  • Myeloma
  • Trisenox (Arsenic Trioxide)
  • +3 more
  • Houston, Texas
    UT MD Anderson Cancer Center
Sep 1, 2020

Multiple Myeloma, Myeloma Trial in Singapore (Daratumumab, Bortezomib, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Myeloma
  • Singapore, Singapore
  • +1 more
May 6, 2020

Myeloma Trial in Houston (Palifermin, Dexamethasone, Gemcitabine)

Completed
Has Results
  • Myeloma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 23, 2020

Carcinoma, Sarcoma, Myeloma Trial in New York (radiation, procedure, other)

Completed
  • Carcinoma
  • +4 more
  • [18F]-SKI-249380
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Apr 24, 2020

Myeloma Trial in Houston (drug, other, procedure)

Completed
Has Results
  • Myeloma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 7, 2020

Testing in Patients Undergoing Hematopoietic Cell

Completed
  • Acute Myeloid Leukemia
  • +5 more
  • Symptom-limited cardiopulmonary exercise test (CPET)
  • +4 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Apr 15, 2020

Myeloma Trial in Baltimore, Philadelphia (biological, other, drug)

Completed
Has Results
  • Myeloma
  • Prevnar- Pneumococcal Conjugate Vaccine (PCV)
  • +3 more
  • Baltimore, Maryland
  • +1 more
Mar 19, 2020

Myeloma, Lymphoma, Leukemia Trial in Richmond (EMR Tailoring, Survey Tailoring, Physician Involvement)

Completed
  • Myeloma
  • +2 more
  • EMR Tailoring
  • +2 more
  • Richmond, Virginia
    Virginia Commonwealth University/Massey Cancer Center
Mar 31, 2020

Testing a Spanish Version of a Patient Toxicity Questionnaire

Completed
  • Breast Cancer
  • +4 more
    • Bethesda, Maryland
      National Cancer Institute (NCI), 9000 Rockville Pike
    Dec 13, 2019

    Place of the Hevylite Test in the Evaluation of MRD in Myeloma

    Unknown status
    • Myeloma
      • Montpellier, France
        Uhmontpellier
      Nov 18, 2019

      Multiple Myeloma, Myeloma, Smoldering Multiple Myeloma Trial run by the NCI ((Anti-KIR))

      Terminated
      Has Results
      • Multiple Myeloma
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Nov 7, 2019

      Myeloma Trial in Houston (DS-3032b)

      Terminated
      • Myeloma
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Nov 13, 2019

      Lymphoma, Leukemia, Myeloma Trial in London (CD62L- Tem)

      Recruiting
      • Lymphoma
      • +6 more
      • CD62L- Tem
      • London, United Kingdom
        UCLH
      Oct 22, 2019

      Leukemia, Myeloma, Myeloproliferative Diseases Trial in Houston (drug, procedure, behavioral)

      Terminated
      Has Results
      • Leukemia
      • +2 more
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Jun 24, 2019

      Myeloma Trial in Switzerland (Nelfinavir, bortezomib, Dexamethasone)

      Completed
      • Myeloma
      • Aarau, Switzerland
      • +11 more
      Jun 24, 2019

      Lymphoma, Solid Malignancy, Alzheimer Trial in New York (drug, device, other)

      Completed
      • Lymphoma
      • +3 more
      • New York, New York
        Memorial Sloan Kettering
      Jun 10, 2019

      Myeloma, Endometrial Cancer Trial in Rochester (BF4)

      Terminated
      Has Results
      • Myeloma
      • Endometrial Cancer
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      May 15, 2019

      Myeloma Trial in Houston (Thalidomide, Lenalidomide, Questionnaires)

      Terminated
      Has Results
      • Myeloma
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Apr 3, 2019

      Myeloma Trial in Belgium, France, Switzerland (lenalidomide, )

      Completed
      • Myeloma
      • Antwerpen, Belgium
      • +76 more
      Apr 25, 2019

      Myeloma Trial in France (Lenalidomide, Bortezomib)

      Completed
      • Myeloma
      • Lenalidomide, Bortezomib
      • Aix-en-provence, France
      • +67 more
      Apr 16, 2019

      Acute Leukaemia, Chronic Leukaemia, Myeloma Trial in Southampton, London (Targeted radiotherapy)

      Completed
      • Acute Leukaemia
      • +3 more
      • Targeted radiotherapy
      • Southampton, Hampshire, United Kingdom
      • +1 more
      Apr 5, 2019

      Myeloma, Transplant-eligible Patients Trial in Lebanon (Ex-vivo expanded effector cells)

      Completed
      Has Results
      • Myeloma
      • Transplant-eligible Patients
      • Ex-vivo expanded effector cells
      • Lebanon, New Hampshire
        Dartmouth-Hitchcock Medical Center
      Mar 1, 2019

      Myeloma Trial in Houston (Panobinostat, Bortezomib, Lenalidomide)

      Completed
      • Myeloma
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Mar 1, 2019

      GVHD, Leukemia, Lymphoma Trial in United Kingdom (CD4 DLI, No DLI)

      Unknown status
      • Graft Versus Host Disease
      • +4 more
      • CD4 DLI
      • No DLI
      • Birmingham, United Kingdom
      • +10 more
      Feb 11, 2019